The European Medicines Agency (EMA) approved vaccines and treatments for COVID-19 in 2021 and strengthened its cyber-capabilities after a 2020 attack. It also extended its mandate and worked on developing a data analysis network. The agency acknowledged the need to improve data collection and coordination and enhance public trust in vaccines. Digital developments, such as AI and machine learning, were central to its activities. The EMA faced a cyber-attack but managed to contain it without affecting its operations. It aims to be prepared for future health threats.
The days of bringing your own device to work could be coming to an end
Security concerns are leading organizations to reevaluate their “bring your own device” (BYOD) policies. With increasing threats to data protection and privacy, many businesses are
